Garrett Brodeur, MD

Professor of Pediatrics and Director, Cancer Predisposition Program
University of Pennsylvania Perelman School of Medicine; Children's Hospital of Philadelphia

Poster(s):

• (P 565) AN EARLY PHASE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF PEEL-224 IN PATIENTS WITH ADVANCED SOLID TUMORS